CancerScope
Matching targeted therapies with gene mutations is associated with better outcomes, even in phase 1 studies
Source
Identifiers
journal ISSN : | 0008-543X |
journal e-ISSN : | 1097-0142 |
DOI | 10.1002/cncr.27843 |